期刊
SEMINARS IN CANCER BIOLOGY
卷 86, 期 -, 页码 1058-1065出版社
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.semcancer.2021.09.007
关键词
Microbiota; Prostate cancer; Genitourinary microbiome; Microbiome; Genitourinary cancers
类别
Prostate cancer is the most frequently diagnosed non-skin malignancy in male patients and there is limited research on the interaction between the disease and the microbiome. Further investigation is needed to understand the impact of microbiota on prostate cancer development, pathogenesis, and treatment response.
Prostate cancer remains the most frequently diagnosed non-skin malignancy in male patients, still representing one of the main causes of cancer-related death worldwide. Evidence is mounting that suggests the putative role of microbiota in the carcinogenesis as well as in modulating the efficacy and activity of anticancer treatments (e.g., chemotherapy, immune checkpoint inhibitors, targeted therapies) in a large number of hematological and solid tumors. However, few data are available regarding the interactions between prostate cancer and microbiome so far, in particular in terms of the impact of microbiota on disease development, pathogenesis, and response to medical treatments in this genitourinary malignancy. Herein, we provide an overview of current knowledge, novel insights and emerging therapeutic approaches related to gastrointestinal and genitourinary microbiome in prostate cancer patients, especially focusing on available evidence and published trials on this topic.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据